ACB Stock Overview
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Aurora Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.35 |
| 52 Week High | CA$6.22 |
| 52 Week Low | CA$1.11 |
| Beta | 2.99 |
| 1 Month Change | 14.41% |
| 3 Month Change | -23.73% |
| 1 Year Change | -77.16% |
| 3 Year Change | -94.14% |
| 5 Year Change | -98.99% |
| Change since IPO | -75.00% |
Recent News & Updates
Recent updates
Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15
Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt
Apr 21Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jan 05A Look At The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)
Nov 13Is Aurora Cannabis (TSE:ACB) Weighed On By Its Debt Load?
Oct 04Aurora Cannabis Inc. (TSE:ACB) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 10Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jul 06Analysts Have Just Cut Their Aurora Cannabis Inc. (TSE:ACB) Revenue Estimates By 19%
May 15A Look At The Fair Value Of Aurora Cannabis Inc. (TSE:ACB)
Mar 21Is Aurora Cannabis' (TSE:ACB) 105% Share Price Increase Well Justified?
Jan 27Aurora Cannabis'(TSE:ACB) Share Price Is Down 86% Over The Past Year.
Sep 02Shareholder Returns
| ACB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -7.5% | -0.4% | -0.6% |
| 1Y | -77.2% | -63.5% | -4.3% |
Return vs Industry: ACB underperformed the Canadian Pharmaceuticals industry which returned -61.7% over the past year.
Return vs Market: ACB underperformed the Canadian Market which returned -4.4% over the past year.
Price Volatility
| ACB volatility | |
|---|---|
| ACB Average Weekly Movement | 10.5% |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 9.8% |
| 10% most volatile stocks in CA Market | 18.8% |
| 10% least volatile stocks in CA Market | 3.8% |
Stable Share Price: ACB is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: ACB's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,338 | Miguel Martin | https://www.auroramj.com |
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market.
Aurora Cannabis Inc. Fundamentals Summary
| ACB fundamental statistics | |
|---|---|
| Market Cap | CA$439.54m |
| Earnings (TTM) | -CA$1.76b |
| Revenue (TTM) | CA$210.49m |
2.1x
P/S Ratio-0.3x
P/E RatioIs ACB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACB income statement (TTM) | |
|---|---|
| Revenue | CA$210.49m |
| Cost of Revenue | CA$210.33m |
| Gross Profit | CA$169.00k |
| Other Expenses | CA$1.76b |
| Earnings | -CA$1.76b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 09, 2023
| Earnings per share (EPS) | -5.40 |
| Gross Margin | 0.08% |
| Net Profit Margin | -834.87% |
| Debt/Equity Ratio | 47.7% |
How did ACB perform over the long term?
See historical performance and comparison